Abstract:Classical swine fever virus (CSFV) is the etiological agent of classical swine fever, a highly contagious dis-ease that causes significant economic losses to the swine industry. Systemic prophylactic immunization with the live attenuated vaccine, the C-strain vaccine, is one of the effective measures for CSF control. However, one of the limitations of the C-strain vaccine is that the field strains-infected animals cannot be differentiated from the C-strain vaccinated herds by serological tests (DIVA). This constraint hampers the practical usage of the C-strain vaccine to eradicate the CSF in China. In the current study, a novel CSF modified live marker vaccine candidate was constructed based on the attenuation of the prevalent 2.1 genotype strain by the deletion of two virulence associated functional residues in the CSFV Erns, H79, and C171. Meanwhile, four residues S14, G22, E24, and E25 were identified specifically for the 6B8 mAb binding to the CSFV E2 as the novel conformational epitope. Then four substitutions of S14K, G22A, E24R, and G25D were further incorporated in the double deletion construct as a negative serolog-ical marker. Finally, the double-deletion marker MLV candidate GD18-ddErnHC-KARD was rescued, and its safety and efficacy profiles were evaluated in piglets. The safety study results indicated that the can-didate did not induce fever, clinical signs, or pathological lesions with a high dose of 105.0 TCID50, and in addition, no virus shedding was detected until 21 days post-inoculation. Meanwhile, the efficacy study results demonstrated that at a low dose of 103.0 TCID50, it conferred complete clinical protection and no virus shedding was detected after the challenge with a highly virulent Shimen strain. Importantly, the infected animals were differentiated using the accompanied DIVA ELISA. These results constitute a proof-of-concept for rationally designing a CSF antigenically marked modified live vaccine candidate.(c) 2022 Elsevier Ltd. All rights reserved.

Expression of E2 Protein of Classical Swine Fever Virus Shimen Strain Using Baculovrius Expression System

Research Article an Improved Bac-to-Bac/BmNPV Technology Expressing Envelope E2 Glycoprotein of Classical Swine Fever Virus (CSFV) in the Silkworm, Bombyx Mori

[Molecular Cloning and Expression of E2 Gene of the Chinese Classical Swine Fever Virus(shimen Strain) and Preliminary Studies of Its DNA Vaccine].

Expression and purification of classical swine fever virus E2 protein from Sf9 cells using a modified vector

Expression of Classical Swine Fever Virus E2 Protein in Escherichia coli and Analysis of Its Immunogenicity

Identification of E2 Strain with Improved Secretion and Immunogenicity Against CSFV in Piglets

Cloning and Prokaryotic Expression of a Section Fragment of Classical Swine Fever Virus E2 Gene

Fusion Expression of E2 Gene of Classical Swine Fever Virus cF114 in Bombyx mori Baculovirus Expression Vector System

Construction of a Chimeric Classical Swine Fever Virus C-strain Containing E2 of Group Ⅱ Isolate Remains and Its Biological Characteristics

Expression of Soluble H1N1 Haemegglutinin in Two Distinct Insect Baculovirus Expression Systems

Generation and immunogenicity analysis of recombinant classical swine fever virus glycoprotein E2 and Erns expressed in baculovirus expression system

Genetic Characterization of E2 Gene of Classical Swine Fever Virus by Restriction Fragment Length Polymorphism and Phylogenetic Analysis.

High expression of the classical swine fever virus (CSFV) envelope protein E2 by a single amino acid mutation and its embedded in the pseudorabies virus (PRV) vector for immunization

E2 and E rns of classical swine fever virus C-strain play central roles in its adaptation to rabbits

Generation and epitope mapping of novel neutralizing monoclonal antibodies against glycoprotein E2 of CSFV

Safety, efficacy, and DIVA feasibility on a novel live attenuated classical swine fever marker vaccine candidate

Hypervariable Antigenic Region 1 of Classical Swine Fever Virus E2 Protein Impacts Antibody Neutralization.

jmbReview The Epitope Recognized by Monoclonal Antibody 2 B 6 in the B / C Domains of Classical Swine Fever Virus Glycoprotein E 2 Affects Viral Binding to Hyperimmune Sera and Replication

Development of Neutralizing Monoclonal Antibody Against E2 Protein of CSFV by Using Pseudovirus and Pseudotyped Virus

Analysis of cross-reactivity of different E2 proteins with antisera of subgroup 2 field isolates and vaccine C-strain of classic swine fever virus

A novel linear epitope at the C-terminal region of the classical swine fever virus E2 protein elicits neutralizing activity